Aktie A0JNAB HUMAN STEM CELLS INSTITUTE
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Human Stem Cells Institute

Aktien

A0JNAB

RU000A0JNAB6

ISKJ

Schlusskurs Moscow Micex - RTS
Andere Börsenplätze
 00:00:00 08.07.2022 		% 5 Tage % 1. Jan.
59,54 RUB +1,43 % Intraday Chart für Human Stem Cells Institute -.--% -.--%
26.04. Artgen Biotech PJSC berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Artgen Biotech PJSC berichtet über die Ergebnisse für das Halbjahr bis zum 30. Juni 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2023
Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2023
Public Joint-Stock Company "Human Stem Cells Institute" Reports Earnings Results for the Full Year Ended December 31, 2022
GENETICO PJSC has completed an IPO in the amount of RUB 178.8 million.
GENETICO PJSC has filed an IPO.
Public Joint-Stock Company "Human Stem Cells Institute" Reports Earnings Results for the Half Year Ended June 30, 2022
Public Joint-Stock Company "Human Stem Cells Institute" announced that it has received RUB 611.63608 million in funding from PJSC International Medical Center Processings and Kriokhraneniya of Biomaterialy
Public Joint-Stock Company "Human Stem Cells Institute" Reports Earnings Results for the Full Year Ended December 31, 2021
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company acquired 6.93% stake in Public Joint-Stock Company "Human Stem Cells Institute".
GENETICO LLC announced that it expects to receive RUB 228.948921 million in funding from Public Joint-Stock Company "Human Stem Cells Institute"
Public Joint-Stock Company Human Stem Cells Institute Reports Earnings Results for the Half Year Ended June 30, 2021
Public Joint-Stock Company "Human Stem Cells Institute" announced that it expects to receive funding from PJSC International Medical Center Processings and Kriokhraneniya of Biomaterialy
Public Joint-Stock Company "Human Stem Cells Institute" announced that it has received RUB 400 million in funding from Limited Liability Company "IceGen 2"
Public Joint-Stock Company Human Stem Cells Institute Reports Earnings Results for the Full Year Ended December 31, 2020
Public Joint-Stock Company "Human Stem Cells Institute" announced that it has received funding from Limited Liability Company "IceGen 2"
Public Joint-Stock Company "Human Stem Cells Institute" and Artur Isaev acquired 17.79% interest in GENETICO LLC from RVC Biopharmaceutical Investments, Limited liability Company, managed by RVC, Investment Arm.
Public Joint-Stock Company "Human Stem Cells Institute" announced that it expects to receive funding from Limited Liability Company "IceGen 2"
An unknown buyer acquired 15% stake in Human Stem Cells Institute PJSC from Mezhdunarodnogo Meditsinskogo Centra Obrabotki i Kriokhraneniya Biomaterialy.
Human Stem Cells Institute PAO Announces Dividend
Artur Isayev acquired 16.68% stake in Human Stem Cells Institute PJSC.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0JNAB Aktie
  4. Nachrichten Human Stem Cells Institute
  5. Andere Sprachen